Search
for
Sort by
Research 151–180 of 1000+
- Psoriatic Skin Lesions Induced by Certolizumab Pegol
- Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women
- Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents
- The antimycotic agent clotrimazole inhibits melanogenesis by accelerating ERK and PI3K-/Akt-mediated tyrosinase degradation
- Sudden whitening of the hair in an 82-year-old woman: the ‘overnight greying’ phenomenon
- Hair Growth Therapy(ies) for Androgenetic Alopecia
- Emerging Therapies for Acne Vulgaris
- The application prospects of honokiol in dermatology
- Medical Management Options for Hair Loss
- Dermocosmetic Aspects of Hair and Scalp
- Hair loss at injection sites of mesotherapy for alopecia
- Frontal fibrosing alopecia in Asians: a retrospective clinical study
- Effect of camouflaging agents on psychologic well-being: A cross-sectional survey of hair loss patients
- Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
- Smoker’s Mustache Revisited: Upper Lip Hair Yellow Discoloration Associated With Tobacco
- Beyond Circadian Rhythm: Melatonin as a Bio-Regulatory Molecule in Skin and Hair Aesthetics
- Minoxidil Toxicosis in Cats and Dogs: A Cross‐Sectional Analysis of Social Media Reports and Public Awareness
- Do non-prescription products help in managing androgenic alopecia?
- The inflammatory component of androgenetic alopecia
- Contraceptive use in acne
- Regenerative Therapies for Cosmetic Dermatology for Patients with Diabetes Mellitus: Skin Aging, Aesthetic Concerns, and Evidence-Based Best Practices
- Microneedling: Where do we stand now? A systematic review of the literature
- Characterizing the role of facial hair in gender identity and expression among transgender men
- СУЧАСНІ ПІДХОДИ ДО ЗАСТОСУВАННЯ ЕМУЛЬГАТОРІВ ТА КОНСЕРВАНТІВ У СКЛАДІ ДЕРМАТОЛОГІЧНИХ ЛІКАРСЬКИХ ЗАСОБІВ
- Stem Cell Use to Treat Dermatological Disorders
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Therapeutic use of caffeine in dermatology: A literature review
- Dermatologic care of the lesbian, gay, bisexual and transgender community of India
- Screening of dermatology drugs for aberrant use‐patterns: An application of epidemiologic estimates and measures of inequality in drug use
- Improving knowledge of hair loss disorders: Assessing the efficacy of a dermatologist-developed social media video library for patient education